Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.

Jun is a transcription factor belonging to the activator protein 1 family. A mutated version of Jun (v-Jun) transduced by the avian retrovirus ASV17 induces oncogenic transformation in avian cell cultures and sarcomas in young galliform birds. The oncogenicity of Jun probably results from transcriptional deregulation of v-Jun-responsive target genes. Here we describe the identification and characterization of a growth-related v-Jun target, a homolog of heparin-binding epidermal growth factor-like growth factor (HB-EGF). HB-EGF is strongly expressed in chicken embryo fibroblasts (CEF) transformed by v-Jun. HB-EGF expression is not detectable or is marginal in nontransformed CEF. Using a hormone-inducible Jun-estrogen receptor chimera, we found that HB-EGF expression is correlated with v-Jun activity. In this system, induction of v-Jun is followed within 1 hr by elevated levels of HB-EGF. In CEF infected with various Jun mutants, HB-EGF expression is correlated with the oncogenic potency of the mutant. Constitutive expression of HB-EGF conveys to CEF the ability to grow in soft agar and to form multilayered foci of transformed cells on a solid substrate. These observations suggest that HB-EGF is an effector of Jun-induced oncogenic transformation.

[1]  K. Mishima,et al.  Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas , 1998, Acta Neuropathologica.

[2]  P. Vogt,et al.  Glutaredoxin is a direct target of oncogenic jun , 1998, Oncogene.

[3]  P. Herrlich,et al.  Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. , 1998, Genes & development.

[4]  G. Besner,et al.  Structure and function of heparin-binding EGF-like growth factor (HB-EGF). , 1998, Frontiers in bioscience : a journal and virtual library.

[5]  J. Woodgett,et al.  An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo , 1998, Current Biology.

[6]  P. Vogt,et al.  Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L. Cantley,et al.  Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. , 1997, Science.

[8]  Michael C. Ostrowski,et al.  Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1 , 1997, Molecular and cellular biology.

[9]  E. Zandi,et al.  AP-1 function and regulation. , 1997, Current opinion in cell biology.

[10]  P. Vogt,et al.  Differential and antagonistic effects of v-Jun and c-Jun. , 1996, Cancer research.

[11]  D. Gillespie,et al.  The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction. , 1996, Oncogene.

[12]  M. Hadman,et al.  Isolation and cloning of JTAP-1: a cathepsin like gene upregulated in response to V-Jun induced cell transformation. , 1996, Oncogene.

[13]  M. Hartl,et al.  Specific activation in jun-transformed avian fibroblasts of a gene (bkj) related to the avian beta-keratin gene family. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Abraham,et al.  Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. , 1995, Genes & development.

[15]  R. Ezzell,et al.  Induction of Heparin-binding EGF-like Growth Factor Expression during Myogenesis , 1995, The Journal of Biological Chemistry.

[16]  P. Vogt,et al.  Efficient induction of fibrosarcomas by v-jun requires mutations in the DNA binding region and the transactivation domain. , 1994, Oncogene.

[17]  A. Dopazo,et al.  Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  K. Kataoka,et al.  Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun , 1994, Molecular and cellular biology.

[19]  M. Karin,et al.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[20]  P. Vogt,et al.  Chimeras of herpes simplex viral VP16 and jun are oncogenic. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[21]  P. Vogt,et al.  Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication. , 1993, Oncogene.

[22]  K. Kataoka,et al.  Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family , 1993, Journal of virology.

[23]  P. Vogt,et al.  A rearranged junD transforms chicken embryo fibroblasts. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  K. Struhl,et al.  Yeast GCN4 as a probe for oncogenesis by AP-1 transcription factors: transcriptional activation through AP-1 sites is not sufficient for cellular transformation. , 1992, Genes & development.

[25]  I. Verma,et al.  Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos. , 1992, Oncogene.

[26]  P. Vogt,et al.  Nuclear translocation of viral Jun but not of cellular Jun is cell cycle dependent. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Vogt,et al.  Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[29]  C. Chang,et al.  Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences. , 1990, Genes & development.

[30]  T. Curran,et al.  Redox regulation of fos and jun DNA-binding activity in vitro. , 1990, Science.

[31]  T. Fleming,et al.  Transformation of NIH3T3 fibroblasts by an expression vector for the human epidermal growth factor precursor. , 1990, Oncogene.

[32]  I. Verma,et al.  mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element , 1990, Molecular and cellular biology.

[33]  N. Jones,et al.  Heterodimer formation between CREB and JUN proteins. , 1990, Oncogene.

[34]  P. Vogt,et al.  The genetics of jun. , 1990, Seminars in Cancer Biology.

[35]  P. Vogt,et al.  The avian cellular homolog of the oncogene jun. , 1988, Oncogene.

[36]  S. McKnight,et al.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. , 1988, Science.

[37]  P. Vogt,et al.  Avian sarcoma virus 17 carries the jun oncogene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Weinberg,et al.  Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. , 1987, Science.

[39]  D. Goeddel,et al.  Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation , 1986, Cell.

[40]  M. Nishizawa,et al.  New procedure for DNA transfection with polycation and dimethyl sulfoxide , 1984, Molecular and cellular biology.

[41]  P. Vogt,et al.  Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis. , 1977, Virology.